You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial

Article metrics

Article menu

Download PDFPDF

XML
Original research
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: July 2020 to January 2023

AbstractFullPdf
Jul 2020979719
Aug 202016316325
Sep 20202142149
Oct 202011411414
Nov 202012112022
Dec 20201021027
Jan 202113013011
Feb 20211121127
Mar 202117517554
Apr 202112212216
May 202113413419
Jun 202112913012
Jul 202114714713
Aug 202117117112
Sep 202117017020
Oct 202111611643
Nov 202116116138
Dec 20211641645
Jan 20221411414
Feb 202299999
Mar 2022767610
Apr 202281828
May 202210110412
Jun 20221051067
Jul 202263632
Aug 202267688
Sep 2022505017
Oct 2022454610
Nov 202240409
Dec 202249506
Jan 2023454822
Total35043515470